Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-27 Purchase |
2024-09-30 7:12 pm |
Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer |
5,000 | $23.41 | $117,050 | 6,000 (Direct) |
View |
| 2024-09-27 Purchase |
2024-09-30 7:10 pm |
Viridian Therapeutics Inc. | VRDN | Mahoney Stephen F. President and CEO |
21,400 | $23.33 | $499,262 | 21,400 (Direct) |
View |
| 2024-09-13 Purchase |
2024-09-17 9:00 pm |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner |
1,600,000 | $18.75 | $30,000,000 | 3,445,813 (Indirect) |
View |
| 2024-01-22 Purchase |
2024-01-24 6:44 pm |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner |
476,190 | $21 | $9,999,990 | 1,845,813 (Indirect) |
View |
| 2023-06-15 Sale |
2023-06-20 5:23 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
2,296 | $28.02 | $64,343 | 104,905 (Direct) |
View |
| 2023-06-02 Sale |
2023-06-06 7:41 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
7,500 | $24.82 | $186,136 | 221,975 (Direct) |
View |
| 2023-04-12 Purchase |
2023-04-12 7:05 pm |
Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer |
4,000 | $25.37 | $101,479 | 259,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-07 Option Award |
2025-04-09 4:26 pm |
N/A 2035-04-07 |
Viridian Therapeutics Inc. | VRDN | Ajer Jeffrey Robert Director |
42,000 | $0 | 42,000 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:36 pm |
N/A 2035-03-10 |
Viridian Therapeutics Inc. | VRDN | Tripuraneni Radhika Chief Medical Officer |
310,700 | $0 | 310,700 (Direct) |
View |
Ownership |
2025-03-12 4:27 pm |
N/A 2034-07-01 |
Viridian Therapeutics Inc. | VRDN | Tripuraneni Radhika Chief Medical Officer |
0 | $0 | 40,000 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:19 pm |
N/A 2035-03-10 |
Viridian Therapeutics Inc. | VRDN | CAIN CHRISTOPHER W. Director |
42,000 | $0 | 42,000 (Indirect) |
View |
| 2025-03-03 Option Award |
2025-03-04 9:17 pm |
N/A 2035-03-03 |
Viridian Therapeutics Inc. | VRDN | Tousignant Jennifer Chief Legal Officer |
144,751 | $0 | 144,751 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 9:14 pm |
N/A 2035-03-03 |
Viridian Therapeutics Inc. | VRDN | Mahoney Stephen F. President and CEO |
513,993 | $0 | 513,993 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 9:13 pm |
N/A 2035-03-03 |
Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer |
263,450 | $0 | 263,450 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 9:12 pm |
N/A 2035-03-03 |
Viridian Therapeutics Inc. | VRDN | Harmon Seth Chief Financial Officer |
175,475 | $0 | 175,475 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:25 pm |
N/A 2034-06-26 |
Viridian Therapeutics Inc. | VRDN | Gheuens Sarah Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:05 pm |
N/A 2034-06-26 |
Viridian Therapeutics Inc. | VRDN | Morris Arlene Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:05 pm |
N/A 2034-06-26 |
Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:05 pm |
N/A 2034-06-26 |
Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director |
21,000 | $0 | 21,000 (Indirect) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:05 pm |
N/A 2034-06-26 |
Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director |
21,000 | $0 | 21,000 (Indirect) |
View |
| 2024-03-28 Other |
2024-04-01 6:32 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner |
49,857 | $0 | 1,990,722 (Indirect) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:05 pm |
N/A 2034-02-12 |
Viridian Therapeutics Inc. | VRDN | Tousignant Jennifer Chief Legal Officer |
290,000 | $0 | 290,000 (Direct) |
View |
| 2024-02-05 Option Award |
2024-02-07 4:01 pm |
N/A 2034-02-05 |
Viridian Therapeutics Inc. | VRDN | Ciulla Thomas Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2024-01-12 4:31 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Ciulla Thomas Chief Medical Officer |
0 | $0 | 570,762 (Direct) |
View |
| 2023-11-10 Option Award |
2023-11-13 5:17 pm |
N/A 2033-11-10 |
Viridian Therapeutics Inc. | VRDN | Harmon Seth See Remarks |
270,000 | $0 | 270,000 (Direct) |
View |
| 2023-10-30 Option Award |
2023-11-01 9:05 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner |
48,463 | $825.37 | 48,463 (Indirect) |
View |
| 2023-10-30 Option Award |
2023-11-01 4:35 pm |
N/A 2023-10-30 |
Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer |
474,400 | $0 | 474,400 (Direct) |
View |
| 2023-10-30 Option Award |
2023-11-01 4:35 pm |
N/A 2033-10-30 |
Viridian Therapeutics Inc. | VRDN | Mahoney Stephen F. President and CEO |
1,259,400 | $0 | 1,259,400 (Direct) |
View |
| 2023-09-21 Option Award |
2023-09-25 4:35 pm |
N/A 2033-09-21 |
Viridian Therapeutics Inc. | VRDN | Gheuens Sarah Director |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2023-09-19 4:30 pm |
N/A 2033-06-01 |
Viridian Therapeutics Inc. | VRDN | Harmon Seth See Remarks |
0 | $0 | 175,000 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 5:23 pm |
N/A 2031-01-18 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
2,297 | $0 | 104,905 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 5:23 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
2,296 | $23.03 | 104,905 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 8:00 pm |
N/A 2023-06-14 |
Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director |
20,000 | $0 | 20,000 (Indirect) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:54 pm |
N/A 2033-06-14 |
Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:54 pm |
N/A 2033-06-14 |
Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director |
20,000 | $0 | 20,000 (Indirect) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:51 pm |
N/A 2033-06-14 |
Viridian Therapeutics Inc. | VRDN | Morris Arlene Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-06 7:41 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
1,875 | $14 | 221,975 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-06 7:41 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
7,500 | $0 | 221,975 (Direct) |
View |
| 2023-06-05 Exercise |
2023-06-06 7:41 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer |
5,625 | $18.51 | 221,975 (Direct) |
View |